Risk Analysis
AUROPHARMA Risk & Volatility Profile
Based on 735 days of price history. Factual statistics, no recommendations.
Annualised Volatility
28.5%
Moderate volatility
Max Drawdown
-34.6%
250 days peak-to-trough
Beta vs Nifty
—
—
Return/Vol Ratio
1.19
Simple Sharpe proxy
Volatility Regime
Moderate — 28.5% annualised
AUROPHARMA has moderate volatility consistent with a typical Indian equity.
Drawdown History
Worst Drawdown
-34.6%
From Aug 24 to Sept 25
250 days of decline
Recovery
Not recovered
Still below the previous peak
Currently 12.0% below the 3-year high
Historical Returns
1 Month
+4.9%
3 Months
+14.1%
1 Year
+24.9%
3 Years
—
52-Week Range
See DCF fair value for AUROPHARMA
Combine risk profile with intrinsic value estimate.
See Fair Value →Risk statistics computed from historical price data. Past volatility does not predict future risk. YieldIQ is not registered with SEBI as an investment adviser.